Specialized care for adrenocortical carcinoma and pheochromocytoma with advanced chemotherapy, targeted therapy, and comprehensive endocrine management.
Expert management of adrenocortical carcinoma and pheochromocytoma with mitotane therapy, chemotherapy combinations, and comprehensive endocrine care. We specialize in hormone-secreting tumors and metastatic disease.
CT, MRI, and PET-CT for accurate staging and assessment of local invasion and metastases.
Comprehensive endocrine evaluation including cortisol, aldosterone, catecholamines, and steroid profiling.
Core needle biopsy, immunohistochemistry, and Weiss criteria for adrenocortical carcinoma grading.
High blood pressure, weight gain, diabetes, facial redness, or hypokalemia from cortisol/aldosterone excess.
Headache, palpitations, sweating (pheochromocytoma); anxiety and tremors during episodes.
Abdominal fullness, flank pain, or incidental adrenal mass on imaging.
Li-Fraumeni, MEN1, Lynch, NF1; family history of endocrine tumors.
Previous abdominal radiation exposure increases risk in some patients.
Adrenal incidentalomas, long-standing endocrine disorders warrant evaluation.
Regular imaging, hormone levels, and mitotane levels for treatment optimization and toxicity management.
Collaboration with endocrine surgery, endocrinology, and radiation oncology specialists.
Managing endocrine side effects, adrenal insufficiency, and maintaining quality of life.